Production and characterization of monoclonal antibodies against vaginolysin: Mapping of a region critical for its cytolytic activity

Toxicon

Volumn 56, Issue 1, 2010, Pages 19-28

  Zvirbliene, Aurelija ^a   Pleckaityte, Milda ^a   Lasickiene, Rita ^a   Kucinskaite Kodze Indre, I ^a   Zvirblis, Gintautas ^a  

^a VILNIUS UNIVERSITY   (Lithuania)

Author keywords

Bacterial vaginosis; Cholesterol dependent cytolysins; Epitope mapping; Gardnerella vaginalis; Monoclonal antibodies; Vaginolysin

Indexed keywords

BACTERIAL TOXIN; CYTOLYSIN; INTERMEDILYSIN; LISTERIOLYSIN; MONOCLONAL ANTIBODY; PERFRINGOLYSIN; PNEUMOLYSIN; STREPTOLYSIN; UNCLASSIFIED DRUG; VAGINOLYSIN;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIBODY STRUCTURE; ANTIGEN RECOGNITION; ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; CROSS REACTION; CYTOLYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; ESCHERICHIA COLI; FEMALE; GARDNERELLA VAGINALIS; HEMOLYSIS; HUMAN; HUMAN CELL; IMMUNOASSAY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN MOTIF; TOXIN ANALYSIS; WESTERN BLOTTING;

AMINO ACID MOTIFS; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; BACTERIAL PROTEINS; BACTERIAL TOXINS; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; FEMALE; GARDNERELLA VAGINALIS; HEMOLYSIS; HEMOLYTIC AGENTS; HUMANS; HYBRIDOMAS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; RECOMBINANT FUSION PROTEINS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; GARDNERELLA VAGINALIS;

EID: 77952553446     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2010.03.007     Document Type: Article

References (31)

1. Aroutcheva A.A., et al. Gardnerella vaginalis isolated from patients with bacterial vaginosis and from patients with healthy vaginal ecosystems. Clin. Infect. Dis. 2001, 33:1022-1027.
2. Bradshaw C.S., et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J. Infect. Dis 2006, 193:1478-1486.
3. Catlin B.W. Gardnerella vaginalis: characteristics, clinical considerations, and contraversies. Clin. Microbiol. Rev. 1992, 5:213-237.
4. Cauci S., et al. Pore-forming and haemolytic properties of the Gardnerella vaginalis cytolysin. Mol. Microbiol. 1993, 9:1143-1155.
5. de los Toyos J.R., et al. Funcional analysis of pneumolysin by use of monoclonal antibodies. Infect. Immun. 1996, 64:480-484.
6. Edelson B.T., Unanune E.R. Intracellular antibody neutralizes Listeria growth. Immunity 2001, 14:503-512.
7. Fredricks D.N., Fiedler T.L., Marrazzo J.M. Molecular identification of bacteria associated with bacterial vaginosis. N. Engl. J. Med. 2005, 353:1899-1911.
8. García-Suárez M.M., et al. Protection against pneumococcal pneumonia in mice ny monoclonal antibodies to pneumolysin. Infect. Immun. 2004, 72:4534-4540.
9. GelberSh E., et al. Functional and phylogenetic characterization of vaginolysin, the human-specific cytolysin from Gardnerella vaginalis. J. Bacteriol. 2008, 190:3896-3903.
10. Giddings K.S., et al. Human CD59 is a receptor for the cholesterol-dependent cytolysin intermedilysin. Nat. Struct. Mol. Biol. 2004, 11:1173-1178.
11. Heuck A.P., et al. Mechanism of membrane insertion of a multimeric beta-barrel protein: perfringolysin O creates a pore using ordered and coupled conformational changes. Mol. Cell. 2000, 6:1233-1242.
12. Hughes T.R., et al. Identification of the high affinity binding site in the Streptococcus intermedius toxin intermedilysin for its membrane receptor, the human complement regulator CD59. Mol. Immunol. 2009, 46:1561-1567.
13. Kirkham L.A.S., et al. Construction and immunological characterization of a novel nontoxic protective pneumolysin mutant for use in future pneumococcal vaccines. Infect. Immun. 2006, 74:586-593.
14. Kohler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975, 256:495-497.
15. Kretzschmar U.M., et al. Ourification and characterization of Gardenerella vaginalis hemolysin. Curr. Microbiol. 1991, 23:7-13.
16. LaChapelle S., et al. Intermedilysin-receptor interactions during assembly of the pore complex. J. Biol. Chem. 2009, 284:12719-12726.
17. Livengood C.H. Bacterial vaginosis: an overview for 2009. Rev. Obstet. Gynecol. 2009, 1:28-37.
18. Nagamune H., et al. Intermedilysin, a novel cytotoxin specific for human cells secreted by Streptococcus intermedius UNS46 isolated from a human liver abscess. Infect. Immun. 1996, 64:3093-3100.
19. Nakauzi A., et al. Passive administration of monoclonal antibodies to anthrolysin O prolong survival in mice lethally infected with Bacillus anthracis. BMC Microbiol. 2008, 8:159.
20. Palmer M. The family of thiol-activated, cholesterol-binding cytolysins. Toxicon 2001, 39:1681-1689.
21. Polekhina G., et al. Insights into the action of the superfamily of cholesterol-dependent cytolysins from studies of intermedilysin. Proc. Natl. Acad. Sci. U.S.A. 2004, 102:600-605.
22. Ramachandran R., et al. Structural insights into the membrane-anchoring mechanism of a cholesterol-dependent cytolysin. Nat. Struct. Biol. 2002, 9:823-827.
23. Ramachandran R., et al. Membrane dependent conformational changes initiate cholesterol-dependent cytolysin oligomerization and intersubunit beta-strand alignment. Nat. Struct. Mol. Biol. 2004, 11:697-705.
24. Randis T.M., et al. Antibody-based detection and inhibition of vaginolysin, the Gardnerella vaginalis cytolysin. PLoS One 2009, 4:e5207.
25. Rossjohn J., et al. Structure of a cholesterol-binding, thiol-activated cytolysin and a model of its membrane form. Cell 1997, 89:685-692.
26. Rottini G., et al. Identification and partial characterization of a cytolytic toxin produced by Gardnerella vaginalis. Infect. Immun. 1990, 58:3751-3758.
27. Soltani C.E., et al. Structural elements of the cholesterol-dependent cytolysins that are responsible for their cholesterol-sensitive membrane interactions. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:20226-20231.
28. Soltani C.E., et al. Specific protein-membrane contacts are required for prepore and pore assembly by a cholesterol-dependent cytolysin. J. Biol. Chem. 2007, 282:15709-15716.
29. Spiegel C.A. Bacterial vaginosis. Clin. Microbiol. Rev. 1991, 4:485-502.
30. Suarez-Alvarez B., et al. Characterisation of mouse monoclonal antibodies for pneumolysin: fine epitope mapping and V gene usage. Immunol. Lett. 2003, 88:227-239.
31. Wilson M.B., Nakane P.K. Recent developments in the periodate method of conjugating horseradish peroxidase (HRPO) to antibodies. Immunofluorescence and Related Techniques 1978, 215-244. Elsevier, Amsterdam. W. Knapp, K. Holubar, G. Wick (Eds.).